HPC
CLX icon

HM Payson & Co’s Clorox CLX Stock Holding History

HM Payson & Co’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$127K Sell
1,335
-140
-9% -$13.4K ﹤0.01% 525
2026
Q1 		$153K Hold
1,475
– – ﹤0.01% 485
2025
Q4 		$149K Sell
1,475
-50
-3% -$5.43K ﹤0.01% 490
2025
Q3 		$188K Sell
1,525
-170
-10% -$21.1K ﹤0.01% 445
2025
Q2 		$204K Sell
1,695
-200
-11% -$26.7K ﹤0.01% 418
2025
Q1 		$279K Hold
1,895
– – ﹤0.01% 361
2024
Q4 		$308K Sell
1,895
-110
-5% -$18K 0.01% 346
2024
Q3 		$327K Sell
2,005
-487
-20% -$72.2K 0.01% 338
2024
Q2 		$340K Hold
2,492
– – 0.01% 325
2024
Q1 		$382K Sell
2,492
-300
-11% -$44.8K 0.01% 315
2023
Q4 		$398K Hold
2,792
– – 0.01% 299
2023
Q3 		$366K Buy
2,792
+400
+17% +$60.8K 0.01% 298
2023
Q2 		$380K Hold
2,392
– – 0.01% 293
2023
Q1 		$379K Hold
2,392
– – 0.01% 285
2022
Q4 		$336K Sell
2,392
-100
-4% -$14.2K 0.01% 297
2022
Q3 		$320K Hold
2,492
– – 0.01% 295
2022
Q2 		$351K Hold
2,492
– – 0.01% 295
2022
Q1 		$346K Buy
2,492
+600
+32% +$91.9K 0.01% 318
2021
Q4 		$330K Hold
1,892
– – 0.01% 333
2021
Q3 		$313K Buy
1,892
+93
+5% +$16K 0.01% 330
2021
Q2 		$324K Hold
1,799
– – 0.01% 324
2021
Q1 		$347K Hold
1,799
– – 0.01% 310
2020
Q4 		$363K Sell
1,799
-12
-0.7% -$2.48K 0.01% 303
2020
Q3 		$381K Sell
1,811
-188
-9% -$41.9K 0.01% 276
2020
Q2 		$439K Hold
1,999
– – 0.01% 246
2020
Q1 		$346K Hold
1,999
– – 0.01% 248
2019
Q4 		$307K Hold
1,999
– – 0.01% 323
2019
Q3 		$304K Hold
1,999
– – 0.01% 320
2019
Q2 		$306K Buy
+1,999
New +$305K 0.01% 323

Other funds holding CLX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

HM Payson & Co's CLX Position: Q2 2026 in Review

HM Payson & Co reduced its Clorox (CLX) stake by 9.5% in Q2 2026, selling an estimated $13.4K and leaving 1,335 shares worth $127K. The position accounts for ﹤0.01% of the portfolio, ranked #525.

HM Payson & Co first reported a position in CLX in Q2 2019 and has held it in 29 quarters since. The position peaked at $439K in Q2 2020. 1,041 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • HM Payson & Co held 1,335 shares of Clorox worth $127K as of Q2 2026.
  • HM Payson & Co sold 140 Clorox shares in Q2 2026, an estimated $13.4K.
  • Clorox made up ﹤0.01% of HM Payson & Co's portfolio in Q2 2026, its #525 holding.
  • HM Payson & Co first reported a position in Clorox in Q2 2019 and has held it in 29 quarters since.
  • HM Payson & Co's Clorox position peaked at $439K in Q2 2020.
  • 1,041 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on HM Payson & Co's 13F filing for Q2 2026, filed 17 Jul 2026.